why choose us

First received: September 11, 2023

Clinical Trial: A Study of Imvotamab in Severe Systemic Lupus Erythematosus

Study Status: Completed

Recruit Status: RECRUITING

Condition: Systemic Lupus Erythematosus

Study Type: INTERVENTIONAL


Official Title: A Phase 1b, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Participants With Severe Systemic Lupus Erythematosus Who Have Fa

Brief Summary: The purpose of this study is to determine the safety and tolerability of imvotamab in patients with severe systemic lupus erythematosus who have failed prior therapies.Participants will be given imvotamab through a vein (i.e., intravenously).

Read more